Compare BIO-TECHNE Corp (TECH) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs US Bancorp — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while US Bancorp trades at $63.14 (market cap $98.36B). The key difference: US Bancorp is far larger — about 8.8× BIO-TECHNE Corp's market cap, and US Bancorp pays the higher dividend (3.29%). Which is the better fit depends on your goals.
| TECH | USB | |
|---|---|---|
Market Cap | $11.16B | $98.36B |
Sector | Health | Financials |
52-Week High | $72.12 | $64.01 |
52-Week Low | $43.31 | $43.94 |
Enterprise Value | $11.24B | — |
Dividend Yield | 0.45% | 3.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
